ESR1 and breast carcinoma: Gene expression array data has shown the luminal family of breast cancer includes at least one high risk subgroup, several intermediate risk subgroups (including a luminal B subgroup), and two good prognosis subgroups comprising a ‘pure’ ER luminal A subgroup and a mixed ER positive/negative subgroup [2].